home / stock / thor / thor news

THOR News and Press, Synthorx Inc. From 04/30/19

Stock Information
Company Name: Synthorx Inc.
Stock Symbol: THOR
Market: NASDAQ
Website: synthorx.com
Menu
THOR THOR Quote THOR Short THOR News THOR Articles THOR Message Board
Get THOR Alerts

News, Short Squeeze, Breakout and More Instantly...
THOR - Synthorx misses by $0.07

Synthorx (NASDAQ: THOR ): Q1 GAAP EPS of -$0.35  misses by $0.07 . More news on: Synthorx, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

THOR - Synthorx Reports First Quarter Financial Results

SAN DIEGO, April 30, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (Nasdaq: THOR), a biotechnology company using a first-of-its-kind Expanded Genetic Alphabet platform technology to discover and develop optimized biologics for cancer and autoimmune disorders, today reported financial results and ...

THOR - Synthorx to Present at H.C. Wainwright Global Life Sciences Conference in London

SAN DIEGO, April 02, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (NASDAQ: THOR), a biotechnology company using a first-of-its-kind Expanded Genetic Alphabet platform technology to discover and develop optimized biologics for cancer and autoimmune disorders, today announced that management will ...

THOR - Synthorx to Present at the American Association of Cancer Research (AACR) Annual Meeting 2019

SAN DIEGO, March 19, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (NASDAQ: THOR), a biotechnology company using a first-of-its-kind Expanded Genetic Alphabet platform technology to discover and develop optimized biologics for cancer and autoimmune disorders, today announced the details of a post...
THOR - Synthorx reports Q4 results

Synthorx (NASDAQ: THOR ): Q4 GAAP EPS of -$2.94. More news on: Synthorx, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

THOR - Synthorx Reports Fourth Quarter and Full Year 2018 Financial Results

Company Positioned for Upcoming 2019 Milestones After Successful IPO Raising $150.7 Million in Gross Proceeds Presented Preclinical Safety and Anti-Tumor Data on Lead Product Candidate THOR-707 at SITC 33rd Annual Meeting; Expect to File Investigational New Drug (IND) Application i...

THOR - Synthorx to Present at the Chinese Society for Clinical Oncology Conference on Immunotherapy

SAN DIEGO, March 12, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (NASDAQ: THOR), a biotechnology company using a first-of-its-kind Expanded Genetic Alphabet platform technology to discover and develop optimized biologics for cancer and autoimmune disorders, today announced the details of an ora...
THOR - Synthorx to Present at the 8th Annual SVB Leerink Global Healthcare Conference

SAN DIEGO, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (NASDAQ: THOR), a biotechnology company using a first-of-its-kind Expanded Genetic Alphabet platform technology to discover and develop optimized biologics for cancer and autoimmune disorders, today announced that Laura Shawver, Ph...

Previous 10 Next 10